{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:17Z","timestamp":1790957657740,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12098-019-03155-4","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T10:02:39Z","timestamp":1578736959000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Immune Thrombocytopenia in Children: Consensus and Controversies"],"prefix":"10.1007","volume":"87","author":[{"given":"Gurpreet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3144-4969","authenticated-orcid":false,"given":"Nicola A. M.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"3155_CR1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1365-2141.2010.08176.x","volume":"149","author":"M Yong","year":"2010","unstructured":"Yong M, Schoonen WM, Li L, et al. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. Br J Haematol. 2010;149:855\u201364.","journal-title":"Br J Haematol"},{"key":"3155_CR2","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA; American Society of Hematology. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190\u2013207.","journal-title":"Blood"},{"key":"3155_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/pbc.20453","volume":"46","author":"P Imbach","year":"2006","unstructured":"Imbach P, Kuhne T, Muller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry I of the intercontinental childhood ITP study group (ICIS). Pediatr Blood Cancer. 2006;46:351\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"3155_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","volume":"2015","author":"DM Arnold","year":"2015","unstructured":"Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2015;2015:237\u201342.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3155_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/pch\/pxy197","volume":"24","author":"JN Friedman","year":"2019","unstructured":"Friedman JN, Beck CE. Diagnosis and management of typical, newly diagnosed primary immune thrombocytopenia (ITP) of childhood. Paediatr Child Health. 2019;24:54\u20135.","journal-title":"Paediatr Child Health"},{"key":"3155_CR6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MOH.0b013e3282ab98f2","volume":"14","author":"AE Geddis","year":"2007","unstructured":"Geddis AE, Balduini CL. Diagnosis of immune thrombocytopenic purpura in children. Curr Opin Hematol. 2007;14:520\u20135.","journal-title":"Curr Opin Hematol"},{"key":"3155_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fped.2017.00179","volume":"5","author":"R Consolini","year":"2017","unstructured":"Consolini R, Costagliola G, Spatafora D. The centenary of immune thrombocytopenia-part 2: revising diagnostic and therapeutic approach. Front Pediatr. 2017;5:179.","journal-title":"Front Pediatr"},{"key":"3155_CR8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","volume":"120","author":"British Committee for Standards in Haematology General Haematology Task Force","year":"2003","unstructured":"British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574\u201396.","journal-title":"Br J Haematol"},{"key":"3155_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0009922810385676","volume":"50","author":"N Bryant","year":"2011","unstructured":"Bryant N, Watts R. Thrombocytopenic syndromes masquerading as childhood immune thrombocytopenic purpura. Clin Pediatr (Phila). 2011;50:225\u201330.","journal-title":"Clin Pediatr (Phila)"},{"key":"3155_CR10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168\u201386.","journal-title":"Blood."},{"key":"3155_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/archpedi.152.4.345","volume":"152","author":"C Calpin","year":"1998","unstructured":"Calpin C, Dick P, Poon A, Feldman W. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia? Arch Pediatr Adolesc Med. 1998;152:345\u20137.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3155_CR12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(97)04143-3","volume":"350","author":"PH Bolton-Maggs","year":"1997","unstructured":"Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997;350:620\u20133.","journal-title":"Lancet."},{"key":"3155_CR13","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2008-03-138487","volume":"112","author":"CE Neunert","year":"2008","unstructured":"Neunert CE, Buchanan GR, Imbach P, et al. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood. 2008;112:4003\u20138.","journal-title":"Blood."},{"key":"3155_CR14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/adc.2006.098442","volume":"92","author":"I Treutiger","year":"2007","unstructured":"Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthoj S, NOPHO ITP Study Group. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity? Arch Dis Child. 2007;92:704\u20137.","journal-title":"Arch Dis Child"},{"key":"3155_CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1182\/blood-2018-02-830844","volume":"132","author":"KMJ Heitink-Polle","year":"2018","unstructured":"Heitink-Polle KMJ, Uiterwaal CSPM, Porcelijn L, et al. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial. Blood. 2018;132:883\u201391.","journal-title":"Blood."},{"issue":"5","key":"3155_CR16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mpd.2002.128547","volume":"141","author":"George R. Buchanan","year":"2002","unstructured":"Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr. 2002;141:683\u20138.","journal-title":"The Journal of Pediatrics"},{"key":"3155_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1651-2227.1998.tb01239.x","volume":"87","author":"MD Carcao","year":"2007","unstructured":"Carcao MD, Zipursky A, Butchart S, Leaker M, Blanchette VS. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr Suppl. 1998;424:71\u20134.","journal-title":"Acta Paediatrica"},{"key":"3155_CR18","doi-asserted-by":"crossref","unstructured":"Zhang J, Liang Y, Ai Y, et al. Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis. Sci Rep. 2018;8:576.","DOI":"10.1038\/s41598-017-19099-8"},{"issue":"10","key":"3155_CR19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s12098-013-1217-2","volume":"81","author":"Deepak Bansal","year":"2013","unstructured":"Bansal D, Rajendran A, Singhi S. Newly diagnosed immune thrombocytopenia: update on diagnosis and management. Indian J Pediatr. 2014;81:1033\u201341.","journal-title":"The Indian Journal of Pediatrics"},{"key":"3155_CR20","first-page":"225-233.e8","volume":"204","author":"Bertrand Lioger","year":"2019","unstructured":"Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T. Efficacy and safety of anti-D immunoglobulins versus intravenous immunoglobulins for immune thrombocytopenia in children: systematic review and meta-analysis of randomized controlled trials. J Pediatr. 2019;204:225\u201333.e8.","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"3155_CR21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1537-2995.2011.03384.x","volume":"52","author":"Jenny M. Despotovic","year":"2011","unstructured":"Despotovic JM, Lambert MP, Herman JH, et al. RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME). Transfusion. 2012;52:1126\u201336; quiz 1125.","journal-title":"Transfusion"},{"key":"3155_CR22","unstructured":"Fujisawa K, Iyori H, Ohkawa H, et al. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Int J Hematol. 2000;72:376\u201383."},{"key":"3155_CR23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5482\/HAMO-16-06-0017","volume":"37","author":"T Kuhne","year":"2017","unstructured":"Kuhne T. Diagnosis and management of immune thrombocytopenia in childhood. Hamostaseologie. 2017;37:36\u201344.","journal-title":"Hamostaseologie."},{"key":"3155_CR24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpeds.2005.04.032","volume":"147","author":"CE Beck","year":"2005","unstructured":"Beck CE, Nathan PC, Parkin PC, Blanchette VS, Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr. 2005;147:521\u20137.","journal-title":"J Pediatr"},{"key":"3155_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/asheducation-2013.1.283","volume":"2013","author":"JM Despotovic","year":"2013","unstructured":"Despotovic JM, Neunert CE. Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia? Hematology Am Soc Hematol Educ Program. 2013;2013:283\u20135.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3155_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pbc.20830","volume":"48","author":"SH O'Brien","year":"2007","unstructured":"O'Brien SH, Ritchey AK, Smith KJ. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer. 2007;48:173\u201380.","journal-title":"Pediatr Blood Cancer"},{"key":"3155_CR27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/vox.12549","volume":"112","author":"B Mayer","year":"2017","unstructured":"Mayer B, Salama A. Successful treatment of bleeding with tranexamic acid in a series of 12 patients with immune thrombocytopenia. Vox Sang. 2017;112:767\u201372.","journal-title":"Vox Sang"},{"key":"3155_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MBC.0b013e3283401490","volume":"21","author":"YH Qin","year":"2010","unstructured":"Qin YH, Zhou TB, Su LN, Lei FY, Zhao YJ, Huang WF. The efficacy of different dose intravenous immunoglobulin in treating acute idiopathic thrombocytopenic purpura: a meta-analysis of 13 randomized controlled trials. Blood Coagul Fibrinolysis. 2010;21:713\u201321.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3155_CR29","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","volume":"114","author":"B Psaila","year":"2009","unstructured":"Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood. 2009;114:4777\u201383.","journal-title":"Blood."},{"issue":"22","key":"3155_CR30","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2012-12-466375","volume":"121","author":"Cindy E. Neunert","year":"2013","unstructured":"Neunert CE, Buchanan GR, Imbach P, et al. Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS). Blood. 2013;121:4457\u201362.","journal-title":"Blood"},{"key":"3155_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00277-010-0950-0","volume":"89","author":"JD Grainger","year":"2010","unstructured":"Grainger JD, Bolton-Maggs PH, Godeau B, et al. Diagnosis and management of chronic ITP: comments from an ICIS expert group. Ann Hematol. 2010;89:11\u20137.","journal-title":"Ann Hematol"},{"key":"3155_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bjh.15090","volume":"181","author":"F Rodeghiero","year":"2018","unstructured":"Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol. 2018;181:183\u201395.","journal-title":"Br J Haematol"},{"issue":"6","key":"3155_CR33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/pbc.21108","volume":"49","author":"Thomas K\u00fchne","year":"2007","unstructured":"Kuhne T, Blanchette V, Buchanan GR, et al. Splenectomy in children with idiopathic thrombocytopenic purpura: a prospective study of 134 children from the Intercontinental Childhood ITP Study Group. Pediatr Blood Cancer. 2007;49:829\u201334.","journal-title":"Pediatric Blood & Cancer"},{"issue":"9","key":"3155_CR34","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00277-016-2738-3","volume":"95","author":"Rayaz Ahmed","year":"2016","unstructured":"Ahmed R, Devasia AJ, Viswabandya A, et al. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children: splenectomy in ITP. Ann Hematol. 2016;95:1429\u201334.","journal-title":"Annals of Hematology"},{"key":"3155_CR35","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1182\/blood-2009-04-210112","volume":"114","author":"SE Crary","year":"2009","unstructured":"Crary SE, Buchanan GR. Vascular complications after splenectomy for hematologic disorders. Blood. 2009;114:2861\u20138.","journal-title":"Blood."},{"key":"3155_CR36","doi-asserted-by":"crossref","first-page":"e27072","DOI":"10.1002\/pbc.27072","volume":"65","author":"NS Bhatt","year":"2018","unstructured":"Bhatt NS, Bhatt P, Donda K, et al. Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia. Pediatr Blood Cancer. 2018;65:e27072.","journal-title":"Pediatr Blood Cancer"},{"key":"3155_CR37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2019.218883","volume":"104","author":"E Lucchini","year":"2019","unstructured":"Lucchini E, Zaja F, Bussel J. Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? Haematologica. 2019;104:1124\u201335.","journal-title":"Haematologica."},{"key":"3155_CR38","doi-asserted-by":"crossref","first-page":"e36698","DOI":"10.1371\/journal.pone.0036698","volume":"7","author":"Y Liang","year":"2012","unstructured":"Liang Y, Zhang L, Gao J, Hu D, Ai Y. Rituximab for children with immune thrombocytopenia: a systematic review. PLoS One. 2012;7:e36698.","journal-title":"PLoS One"},{"key":"3155_CR39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ajh.25479","volume":"94","author":"RF Grace","year":"2019","unstructured":"Grace RF, Shimano KA, Bhat R, et al. Second-line treatments in children with immune thrombocytopenia: effect on platelet count and patient-centered outcomes. Am J Hematol. 2019;94:741\u201350.","journal-title":"Am J Hematol"},{"key":"3155_CR40","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1182\/blood-2011-11-393975","volume":"119","author":"VL Patel","year":"2012","unstructured":"Patel VL, Mahevas M, Lee SY, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012;119:5989\u201395.","journal-title":"Blood."},{"key":"3155_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(16)00279-8","volume":"388","author":"MD Tarantino","year":"2016","unstructured":"Tarantino MD, Bussel JB, Blanchette VS, et al. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388:45\u201354.","journal-title":"Lancet."},{"key":"3155_CR42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3324\/haematol.2018.202283","volume":"104","author":"MD Tarantino","year":"2019","unstructured":"Tarantino MD, Bussel JB, Blanchette VS, et al. Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia. Haematologica. 2019;104:2283\u201391.","journal-title":"Haematologica."},{"issue":"8","key":"3155_CR43","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/pbc.26003","volume":"63","author":"Cindy Neunert","year":"2016","unstructured":"Neunert C, Despotovic J, Haley K, et al. Thrombopoietin receptor agonist use in children: data from the pediatric ITP Consortium of North America ICON2 study. Pediatr Blood Cancer. 2016;63:1407\u201313.","journal-title":"Pediatric Blood & Cancer"},{"key":"3155_CR44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/CEOR.S177338","volume":"Volume 10","author":"Gabriel Tremblay","year":"2018","unstructured":"Tremblay G, Dolph M, Bhor M, et al. Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia. Clinicoecon Outcomes Res. 2018;10:715\u201321.","journal-title":"ClinicoEconomics and Outcomes Research"},{"key":"3155_CR45","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/bloodadvances.2017010660","volume":"2","author":"J Despotovic","year":"2018","unstructured":"Kim TO, Despotovic J, Lambert MP. Eltrombopag for use in children with immune thrombocytopenia. Blood Adv. 2018;2:454\u201361.","journal-title":"Blood Adv"},{"key":"3155_CR46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-0609.2005.00545.x","volume":"75","author":"S Damodar","year":"2005","unstructured":"Damodar S, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients. Eur J Haematol. 2005;75:328\u201331.","journal-title":"Eur J Haematol"},{"key":"3155_CR47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/09537104.2014.886677","volume":"26","author":"AP Patel","year":"2015","unstructured":"Patel AP, Patil AS. Dapsone for immune thrombocytopenic purpura in children and adults. Platelets. 2015;26:164\u20137.","journal-title":"Platelets."},{"key":"3155_CR48","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/bloodadvances.2019000279","volume":"3","author":"CE Neunert","year":"2019","unstructured":"Neunert CE, Rose MJ. Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice. Blood Adv. 2019;3:1907\u201315.","journal-title":"Blood Adv"},{"issue":"10004","key":"3155_CR49","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(15)61107-2","volume":"386","author":"John D Grainger","year":"2015","unstructured":"Grainger JD, Locatelli F, Chotsampancharoen T, et al. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;386:1649\u201358.","journal-title":"The Lancet"},{"key":"3155_CR50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pbc.22346","volume":"54","author":"D Bansal","year":"2010","unstructured":"Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK. Outcome of chronic idiopathic thrombocytopenic purpura in children. Pediatr Blood Cancer. 2010;54:403\u20137.","journal-title":"Pediatr Blood Cancer"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-03155-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-019-03155-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-03155-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:10:02Z","timestamp":1695600602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-019-03155-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["3155"],"URL":"https:\/\/doi.org\/10.1007\/s12098-019-03155-4","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}